Indane derivatives as modulators of ion channels

Details for Australian Patent Application No. 2006254809 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kawatkar, Aarti S.; Termin, Andreas; Martinborough, Esther; Neubert, Timothy

Agent Cullens

Pub. Number AU-B-2006254809

PCT Pub. Number WO2006/133459

Priority 60/688,919 09.06.05 US

Filing date 9 June 2006

Wipo publication date 14 December 2006

Acceptance publication date 15 March 2012

International Classifications

C07D 277/52 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133459 Priority application(s): WO2006/133459

15 March 2012 Application Accepted

  Published as AU-B-2006254809

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254819-System for routing a trading order based upon quantity

2006254796-Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes